The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period
We describe the immediate- and longer-term direct medical costs of care for individuals diagnosed with HIV at CD4 counts <350/mm3 (“late presenters”). We collected and stratified by initial CD4 count all inpatient, outpatient, and drug costs for all newly diagnosed patients accessing HIV care wit...
Main Authors: | Hartmut B. Krentz, M. John Gill |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | AIDS Research and Treatment |
Online Access: | http://dx.doi.org/10.1155/2012/757135 |
Similar Items
-
Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
by: C Scott Mahan, et al.
Published: (2010-02-01) -
Anician women : Patronage and dynastic strategy in a late Roman Domus, 350c
by: Kurdock, Anne Nancy
Published: (2003) -
Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
by: Hartmut Krentz PhD, et al.
Published: (2019-01-01) -
Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
by: Vivek Jain, et al.
Published: (2015-01-01) -
HIV-Infected Late Presenter Patients
by: Antonella D'Arminio Monforte, et al.
Published: (2012-01-01)